Deanna M. Petersen
Net worth: 223 986 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Roger Deschenes | M | 65 | 3 years | |
| Earl Lewis | M | 79 | 12 years | |
| John Whiting | M | 63 | 6 years | |
| Brian Corvese | M | 67 | 17 years | |
| Timothy Wright | M | 66 | 18 years | |
| Søren Tulstrup | M | 59 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 12 years |
| Leslie Waltke | F | - | 12 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bonnie Jean Brown | F | 61 | 5 years | |
| John Hatsopoulos | M | 90 | 17 years | |
| Erik Ostrowski | M | 51 | 5 years | |
| Charles T. Maxwell | M | 92 | 18 years | |
| Anthony S. Loumidis | M | 60 | 12 years | |
| Shalini Sharp | F | 49 | 15 years | |
| Graham Hetherington | M | 65 | 6 years | |
| Gabriel J. Parmese | M | 64 | 1 years | |
| Jesse T. Herrick | M | 45 | 1 years | |
| Susan Kilsby | F | 65 | 8 years | |
| Angus Russell | M | 68 | 14 years | |
| Robert Panora | M | 69 | - | |
| Karen Valentine | F | 52 | 14 years | |
| Philip Vickers | M | 64 | 13 years | |
| Kim Warren | M | - | 5 years | |
| George N. Hatsopoulos | M | 97 | 12 years | |
| James Bowling | M | 56 | 10 years | |
| Suzanne Bruhn | M | 60 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 14 years |
| Scott Applebaum | M | 57 | 2 years | |
| Barry J. Sanders | M | 63 | 14 years | |
| Joshua Resnick | M | 49 | 2 years | |
| Katina Dorton | F | 66 | 1 years | |
| Bruce Booth | M | 49 | 8 years | |
| Dominic Blakemore | M | 54 | 4 years | |
| Flemming Ørnskov | M | 66 | 6 years | |
| Christopher Paige | M | 71 | 8 years | |
| Steven Avruch | M | 63 | 5 years | |
| Annalisa Jenkins | M | 58 | 6 years | |
| Keith Davidson | M | 73 | 3 years | |
| Frank Alexander Mlynarczyk | M | 81 | 5 years | |
| Philip Donenberg | M | 63 | - | |
| David R. Ginsburg | M | 71 | 8 years | |
| Scott Requadt | M | 56 | 2 years | |
| Ian Karp | M | - | 5 years | |
| John Cerio | M | - | - | |
| Anne Minto | F | 70 | 8 years | |
| Adam F. Krauss | M | 51 | 15 years | |
| Wadih Jordan | M | 89 | 19 years | |
| William Burns | M | 76 | 8 years | |
| Matthew Emmens | M | 72 | 11 years | |
| Azadeh Golipour | M | - | 8 years | |
| Ian Clark | M | 62 | 6 years | |
| Kerry Wentworth | F | 51 | 10 years | |
| Justin Renz | M | 52 |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | 3 years |
| Ralph Jenkins | M | - | 1 years | |
| Steven Gillis | M | 71 | 7 years | |
| Christopher Mason | M | 66 | 7 years | |
| Bruce A. Leicher | M | 68 | 1 years | |
| David Stout | M | 70 | 6 years | |
| Russell Herndon | M | 65 | 5 years | |
| Barbara H. Deptula | F | 69 |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | 12 years |
| Charles E. Yon | M | - |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | - |
| Fred Holubow | M | 85 | 3 years | |
| Laurence E. de Armada Garcia Roosevelt | F | 45 | 1 years | |
| Chuck Yon | M | - |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | 7 years |
| Jonathan Lewis | M | 65 | 3 years | |
| Miguel Coego Rios | M | - | 8 years | |
| Emmanuel Dulac | M | 55 | 2 years | |
| Daryl DeKarske | M | - | 7 years | |
| Joanne Cordeiro | F | 66 | 8 years | |
| Adi Mohanty | M | 57 | 9 years | |
| Georgette Verdin | F | - | - | |
| David McMullin | M | - | 2 years | |
| Robert J. Dempsey | M | - | - | |
| Paul Streck | M | 60 | 2 years | |
| Scott Hunter | M | - | - | |
| Debra Silberg | M | - | - | |
| Margaret Eisen | F | 70 | 6 years | |
| Iain Ward | M | - | 8 years | |
| Mark Enyedy | M | 60 | 3 years | |
| Alastair J. J. Wood | M | 77 | - | |
| Jeffrey Leiden | M | 68 | 6 years | |
| David Mott | M | 58 | 2 years | |
| Noubar Afeyan | M | 60 | 8 years | |
| Martin Taylor | M | 72 | 4 years | |
| Barry James Price | M | 80 | 14 years | |
| Patrick J. Langlois | M | 78 | 6 years | |
| Kathleen Anne Nealon | F | 70 | 4 years | |
| Michael Rosenblatt | M | 76 | 1 years | |
| Hyam Levitsky | M | 66 | 5 years | |
| Axel Hoos | M | 54 | 4 years | |
| Perry Sternberg | M | 55 | 6 years | |
| David Colpman | M | 62 | 15 years | |
| Charlotte Sibley | F | 77 | 5 years | |
| Michele Galen | F | 67 | 1 years | |
| Ginger Gregory | M | 56 | 3 years | |
| Raymond Pratt | M | 73 | 7 years | |
| Wei Wu | M | - | 5 years | |
| Blaine McKee | M | 59 | 4 years | |
| Arthur Tzianabos | M | 60 | 8 years | |
| Brooke Clarke | F | - | 5 years | |
| Theresa Heggie | F | 63 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 years |
| Kirsten Dupuis | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 58 | 58.00% |
| Ireland | 45 | 45.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Deanna M. Petersen
- Personal Network
